asco gu23 treatment-free survival in kidney cancer | dana-farber cancer institute
Published 1 year ago • 86 plays • Length 2:29Download video MP4
Download video MP3
Similar videos
-
1:19
asco gu23 triplet therapy in kidney cancer: toni choueiri, md | dana-farber cancer institute
-
20:39
kidney cancer conference highlights from asco gu 2023
-
1:01
asco gu23 toni choueiri, md: keynote-564 subgroup analysis | dana-farber cancer institute
-
1:30
kidney cancer research: immunotherapy after surgery | dana-farber cancer institute
-
1:28
kidney cancer javelin 101: toni choueiri, md | dana-farber cancer institute
-
22:31
kidney cancer conference highlights from asco 2022
-
26:44
kidney cancer conference highlights from asco 2023
-
2:12
asco23: toni choueiri, md | dana-farber cancer institute
-
2:07
kidney cancer immunotherapy | dana-farber cancer institute
-
1:22
asco gu23 toni choueiri, md: checkmate-9er 3-year follow-up | dana-farber cancer institute
-
2:08
dana-farber cancer institute: toni k. choueiri, md at asco gu 21 (kidney cancer)
-
1:42
dana-farber cancer institute: toni k. choueiri, md (kidney cancer research at asco gu21)
-
1:28
kidney cancer research presented by dana-farber at asco 20
-
2:41
living with kidney cancer | dana-farber cancer institute
-
1:08
asco gu23 checkmate-9er biomarker analysis: toni choueiri, md | dana-farber cancer institute
-
2:43
asco gu 23 penile cancer research | dana-farber cancer institute
-
1:15
kidney cancer research: follow-up on immunotherapy after surgery | dana-farber cancer institute
-
25:09
kidney cancer highlights from esmo 2022
-
1:38
kidney cancer (papillary renal cell carcinoma) research presented by dana-farber at asco 20